HPV testing for cervical cancer screening appears more cost-effective than Papanicolau cytology in Mexico

被引：0
|
作者：
Yvonne N. Flores
David M. Bishai
Attila Lőrincz
Keerti V. Shah
Eduardo Lazcano-Ponce
Mauricio Hernández
Víctor Granados-García
Ruth Pérez
Jorge Salmerón
机构：
[1] Instituto Mexicano del Seguro Social,Unidad de Investigación Epidemiológica y en Servicios de Salud
[2] Johns Hopkins University,Department of Population, Family, and Reproductive Health
[3] Bloomberg School of Public Health,Wolfson Institute of Preventive Medicine, Barts and The London School of Medicine
[4] Queen Mary University of London,Department of Molecular Microbiology and Immunology
[5] Johns Hopkins University,Centro de Investigación en Salud Poblacional
[6] Bloomberg School of Public Health,Secretaria de Prevención y Promoción de la Salud
[7] Instituto Nacional de Salud Pública,Unidad de Investigación en Economía de la Salud
[8] Secretaría de Salud,Departamento de Abastecimiento, Instituto Mexicano del Seguro Social
[9] Instituto Mexicano del Seguro Social,undefined
[10] Hospital General Regional No. 1,undefined
来源：
Cancer Causes & Control | 2011年 / 22卷
关键词：
Cost-effectiveness; Cervical cancer; HPV; Screening; Mexico;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：261 / 272
页数：11
相关论文
共 50 条
  • [41] Cost-Effectiveness of Primary HPV Testing, Cytology and Co-testing as Cervical Cancer Screening for Women Above Age 30 Years
    Xian Wen Jin
    Laura Lipold
    Julie Foucher
    Andrea Sikon
    Jennifer Brainard
    Jerome Belinson
    Sarah Schramm
    Kelly Nottingham
    Bo Hu
    Michael B. Rothberg
    Journal of General Internal Medicine, 2016, 31 : 1338 - 1344
  • [42] Cost Paradox in Cercival Cancer Screening in South India: Expensive HPV Is a Better Screening Test Than Less Expensive Techniques: Comparison of VIA, Cytology and HPV Testing
    Dewar, R.
    Khadapkar, R.
    Jeyapandi, S.
    Khan, A.
    Das, B. R.
    LABORATORY INVESTIGATION, 2013, 93 : 87A - 87A
  • [43] HPV mRNA testing in cervical cancer screening
    Arbyn, Marc
    Canfell, Karen
    Poljak, Mario
    Berkhof, Johannes
    de Sanjose, Silvia
    Wentzensen, Nicolas
    LANCET ONCOLOGY, 2022, 23 (10): : E437 - E437
  • [44] Cost Paradox in Cercival Cancer Screening in South India: Expensive HPV Is a Better Screening Test Than Less Expensive Techniques: Comparison of VIA, Cytology and HPV Testing
    Dewar, R.
    Khadapkar, R.
    Jeyapandi, S.
    Khan, A.
    Das, B. R.
    MODERN PATHOLOGY, 2013, 26 : 87A - 87A
  • [45] HPV testing for primary cervical cancer screening
    Ronco, Guglielmo
    Segnan, Nereo
    LANCET, 2007, 370 (9601): : 1740 - 1742
  • [46] HPV testing for cervical cancer screening in Croatia
    Grce, Magdalena
    Grahovac, Blazenka
    Rukavina, Tomislav
    Vrdoljak-Mozetic, Danijela
    Glavas-Obrovac, Ljubica
    Kaliterna, Vanja
    Zele-Starcevic, Lidija
    COLLEGIUM ANTROPOLOGICUM, 2007, 31 : 67 - 71
  • [47] Cost-effectiveness of primary cytology and HPV DNA cervical screening
    Bistoletti, Peter
    Sennfalt, Karin
    Dillner, Joakim
    INTERNATIONAL JOURNAL OF CANCER, 2008, 122 (02) : 372 - 376
  • [48] HPV testing for primary cervical cancer screening
    不详
    REPRODUCTIVE HEALTH MATTERS, 2008, 16 (32) : 194 - 195
  • [49] HPV DNA testing for cervical cancer screening
    Wright, Thomas C., Jr.
    INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2006, 95 : S239 - S246
  • [50] Levalbuterol is not more cost-effective than albuterol for COPD
    Hendeles, L
    Hartzema, A
    CHEST, 2003, 124 (03) : 1176 - 1176
12345